Homology Medicines, Inc.
GENE THERAPY METHODS
Last updated:
Abstract:
Provided are methods for reducing the risk of occurrence and/or the severity of pathogenic diseases (e.g., diseases associate with varicella zoster virus reactivation, influenza infection, and/or S. pneumoniae infection) in a subject that is receiving a gene therapy and an accompanying immunosuppressant regimen.
Status:
Application
Type:
Utility
Filling date:
5 Nov 2021
Issue date:
26 May 2022